
FDA approves phase 1/2 clinical trial with ABX196 in patients with liver cancer ABX196 to be tested in combination with checkpoint inhibitor nivolumab to treat hepatocellular carcinoma
May 14, 2019
LA JOLLA, CA The U.S. Food and Drug Administration has approved an investigational new drug (IND) application for a phase 1/2 clinical trial of ABX196, a liver cancer therapy developed in the laboratory of Scripps Research Professor Luc Teyton, MD, PhD, and licensed to French pharmaceutical company Abivax.
The FDA approval allows Abivax testing of ABX196 in patients with hepatocellular carcinoma (HCC), the most common form of liver cancer. ABX196 showed potent efficacy against HCC in preclinical testing.
The translation of basic research discoveries to the clinic is the greatest achievement we can hope for as clinician scientists. says Teyton, who is also a member of Abivax's Scientific Advisory Board. The use of ABX196 in the context of immunotherapy has been shown to be beneficial in multiple animal models of cancer, but the results with hepatocellular carcinoma are spectacular. We are looking forward to impacting the disease in patients, especially given the limitations of current therapies.
The open IND allows Abivax to test ABX196 in combination with nivolumab (Opdivo, Bristol-Myers Squibb), a checkpoint inhibitor, in a first phase 1/2 clinical trial to treat patients with HCC. The initial dose-escalation phase of the study will be conducted at the Scripps MD Anderson Cancer Center in San Diego, California, USA; additional leading cancer centers in the U.S. will be involved in the subsequent expansion phase of the study. The first patient is expected to be enrolled this summer.
We are thrilled to have been given the green light by FDA for our U.S. study. says Hartmut J. Ehrlich, MD, chief executive officer of Abivax. This open IND allows Abivax, in collaboration with leading key opinion leaders at internationally renowned U.S. cancer centers of excellence, to explore the clinical potential of our iNKT agonist ABX196 to broaden and potentiate the activity of the checkpoint inhibitor nivolumab. Based on its unique mechanism of action and exciting preclinical data in several cancer models, we believe ABX196 is a promising immunotherapeutic product candidate for patients with liver cancer that may also have potential in other cancers.
ABX196 is a synthetic glycolipid agonist of invariant natural killer T cells (iNKT) in a liposomal formulation. A phase 1 clinical trial conducted by Abivax in healthy volunteers has been completed and demonstrated safety and tolerability as well as a potent activation of iNKT cells. ABX196, both alone and in combination with a checkpoint inhibitor, showed a statistically highly significant therapeutic effect in reducing tumor growth as measured by MRI and increasing survival in mice with HCC. Abivax holds exclusive rights to ABX196 from Scripps Research, the University of Chicago, and Brigham Young University.
Despite the recent introduction of checkpoint inhibitors, hepatocellular carcinoma continues to be a substantial therapeutic challenge, as only about 20 percent of the treated patients show a response to these new drugs says Darren Sigal, MD, program director of GI Oncology at Scripps Clinic and Scripps MD Anderson Cancer Center in San Diego, and principal investigator of the study. While checkpoint inhibitors block a do not attack me' signal on cancer cells, ABX196 activates iNKT cells, a subpopulation of lymphocytes that is critical for mounting an effective immune response. The synergy between these two molecules carries substantial promise for improved outcomes for patients with this deadly cancer.
Checkpoint inhibitors like nivolumab are a leading class of therapeutic monoclonal antibodies that block certain endogenous proteins (PD-1/PDL-1) made by immune cells, such as T cells, as well as some cancer cells. These proteins effectively hijack the immune system, causing it to keep immune responses in check and preventing T cells from killing cancer cells. When these proteins are blocked, the brakes on the immune system are released and T cells are able to kill cancer cells much more efficiently. In some cancers, treatment with checkpoint inhibitors has been highly efficacious. However, due to the tumor micro-environment in other cancers, such as HCC, checkpoint inhibitors can have difficulties exerting their effects. ABX196 is intended as a drug that will potentiate the efficacy of checkpoint inhibitors by activating iNKT cells to kill tumor cells.
HCC is the most common form (75 to 90 percent) of primary liver cancer in adults. It typically occurs in the setting of chronic liver inflammation and/or cirrhosis and is closely linked to chronic viral infection such as hepatitis B or C, exposure to toxins such as alcohol, and to certain diseases such as non-alcoholic steatohepatitis (NASH).
The incidence of and deaths related to HCC are increasing in the United States and globally due to hepatitis B and C virus infections, as well as NASH. Prevalence data from 2018 show a total of 79,000 cases of HCC in the U.S. and G5 Europe (Germany, France, Italy, Spain and the UK), with 67,000 new cases, and a total of 260,000 cases in China with 338,000 new cases. Globally, there were 841,000 new cases of liver cancer (ranking it sixth of all reported cancers) and 782,000 fatalities (ranking it fourth) in 2018.
Currently, the American Cancer Society reports five-year survival rates in the U.S. of 31 percent for localized HCC, 11 percent for regional, and 2 percent for distant or metastatic, indicating a clear unmet medical need for improved therapies for HCC.
Cancer Immunology & Microbiology Teyton, Luc
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
21/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
21/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
21/11/2026
A larger studio puts more distance between the lights and the people who need to look good under them. Brightline Lighting, a manufacturer of energy-efficient l...
21/11/2026
LA JOLLA, CA-Despite its enormous impact on individuals, families and communities, addiction remains an area of significant unmet medical need.
A $7 million gi...
21/11/2026
27 FANGORIA Chainsaw Awards Nominees Created with Blackmagic Design
Brie Clayton November 20, 2026
0 Comments
Blackmagic Design hardware and software ...
20/11/2026
The sports broadcaster's chairman sees the upcoming game as an opportunity t...
20/11/2026
In-venue and creative video staffers at the professional and collegiate level have one major thing in common: the intensity and attention to detail ramps up dur...
20/11/2026
A variety of LED displays, integrated broadcast infrastructure covers every angl...
20/11/2026
Real American Freestyle (RAF) has announced a distribution partnership with Migu Video, a Chinese digital sports platform, to carry the RAF15 main event between...
20/11/2026
Apple and F1 Academy have announced that the all-female racing series will stream on Apple TV in the U.S. beginning in 2027. Fans will be able to watch every qu...
20/11/2026
Regional broadcaster m nchen.tv has modernized its production infrastructure at a new location in northern Munich. Riedel MediorNet provides decentralized signa...
20/11/2026
Eutelsat has announced three appointments to its Executive Committee, effective November 2026, under CEO Jean-Fran ois Fallacher.
Jean-Hubert Lenotte is appoin...
20/11/2026
After more than two decades at Harbour Esplanade in Docklands, the Seven Network has relocated its Melbourne headquarters to a new, custom-built ST 2110 facilit...
20/11/2026
Brazil is among the first markets deploying Versatile Video Coding (VVC) as part...
20/11/2026
The Soccer Tournament (TST), the $1 million winner-take-all 7v7 world championsh...
20/11/2026
Enhancements include a larger compound, an elevated camera count, and a whole lo...
20/11/2026
Leaders from ESPN, iHeartMedia, and Just Women's Sports explore creating new...
20/11/2026
New EQ plug-in aimed at mastering duties
Lemur Audio's latest plug-in has just arrived, delivering a characterful EQ that's aimed primarily at maste...
20/11/2026
Discounts of up to 75% now available
Soundtoys' annual Black Friday sale is now live, with discounts of up to 75% applied across the company's range...
20/11/2026
New creative looping tool revealed
Described as a cycling audio fragmenter , the latest addition to the SoundGhost range draws its inspiration from tape ph...
20/11/2026
Fairchild recreation gets plug-in counterpart
Heritage Audio's Herchild 670 offers a meticulous hardware recreations of the much-loved Fairchild 670 and...
20/11/2026
BONDI: 7 Minutes That Changed Australia
16 November, 2026
Media releases
A landmark documentary chronicling the worst terror attack in modern Australian hi...
20/11/2026
Statement regarding SBS non-Executive Director Aaron Fa'Aoso
20 November, 2026
Media releases
Aaron Fa'Aoso has advised that he is stepping down a...
20/11/2026
INVITATION FOR PUBLIC COMMENTS AND OBJECTIONS ON NOMINEES FOR APPOINTMENT TO THE COUNCIL OF THE NATIONAL FILM AND VIDEO FOUNDATION (NFVF) The Department of Spor...
20/11/2026
UEFA Nations League football and autumn premieres propel TVP to number one as YouTube grows its TV screen share
Warsaw, Poland, November 19, 2026 - Nielsen, a...
20/11/2026
October's autumn weather clearly encouraged Poles to spend more time in front of their screens, resulting in both longer viewing times and a higher overall ...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
DigitalGlue releases creative.space Pulse, a free Mac app that shows creatives w...
20/11/2026
How NBCUniversal Telemundo Used Virtual Production for its FIFA World Cup 2026 C...
20/11/2026
What Film School Pays and What it Costs: The Federal Numbers
Mark Santos November 20, 2026
0 Comments
Every editor has had the argument about film sch...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Beam Dynamics has introduced new Model Context Protocol (MCP) support, expanding how customers can work with the live operational data held in Beam. The new cap...
20/11/2026
Re:Vision Effects Cyber Week Sale Nov 24 to Nov 30
Pierre Jasmin November 19, 2026
0 Comments
Long time friends of the COW are up with a big sale!
Us...
20/11/2026
Avid is offering up to 33% off annual subscriptions!
Brie Clayton November 19, 2026
0 Comments
Hero image courtesy Deposit Photos
Pro Tools
Pro To...
19/11/2026
With a sports-bar vibe and all the teams onsite in a huge atrium in Ballpark Vil...
19/11/2026
The senior from Phoenix and England is balancing life as a Division I tennis player with a growing career behind the microphone
The future of live sports produ...
19/11/2026
RED Digital Cinema and Colorfront have partnered to integrate native Colorfront color management into RED Connect, letting productions apply Colorfront's co...
19/11/2026
SMPTE has published an engineering report summarizing an industry survey by its Study Group on Content Provenance and Authenticity in Media. The findings point ...
19/11/2026
CTech and Skyline Communications have announced a partnership to deliver integra...
19/11/2026
Euskal Irrati Telebista (EITB), the Basque Country's public media group, has completed Phase 1 of a five-studio renewal with the commissioning of a Lawo IP ...
19/11/2026
The Esports Foundation (EF) has announced an expanded Road to ENC 2027 for the E...
19/11/2026
All Women's Sports Network (AWSN) held its first awards show, VEON: Women W...
19/11/2026
Gracenote, the content intelligence business unit of Nielsen, has extended its relationship with DIRECTV. Gracenote will continue to supply visual imagery and p...